Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petra Dickmann
Stephan Becker

Showing results (221-230 of 299) with videos related to

Pageof 30
Sort By:
Virology|July 30, 2005
LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirusThomas Gramberg, Heike Hofmann, Peggy Möller, et al.
The Journal of Infectious Diseases|April 16, 2013
Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu)Ariel Sobarzo, Allison Groseth, Olga Dolnik, et al.
The Journal of Antimicrobial Chemotherapy|April 9, 2014
The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entryGerrit Gehring, Katrin Rohrmann, Nkacheh Atenchong, et al.
Plos Neglected Tropical Diseases|May 2, 2017
External quality assessment study for ebolavirus PCR-diagnostic promotes international preparedness during the 2014 - 2016 Ebola outbreak in West AfricaHeinz Ellerbrok, Sonja Jacobsen, Pranav Patel, et al.
Clinical Chemistry and Laboratory Medicine|August 2, 2012
Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogensThomas Strecker, Jennifer Uhlendorff, Sandra Diederich, et al.
Cell Reports. Medicine|July 20, 2022
Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccineLeonie M Weskamm, Anahita Fathi, Matthijs P Raadsen, et al.
Structure (London, England : 1993)|July 1, 2023
The C-terminus of Sudan ebolavirus VP40 contains a functionally important CX<sub>n</sub>C motif, a target for redox modificationsAnke-Dorothee Werner, Martin Schauflinger, Michael J Norris, et al.
Vaccines|April 23, 2022
Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus NucleoproteinAlexandra Kupke, Asisa Volz, Erik Dietzel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 21, 2015
Field Evaluation of Capillary Blood Samples as a Collection Specimen for the Rapid Diagnosis of Ebola Virus Infection During an Outbreak EmergencyThomas Strecker, Bernadett Palyi, Heinz Ellerbrok, et al.
PNAS Nexus|November 16, 2022
Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic testJohannes Roessler, Dagmar Pich, Manuel Albanese, et al.
Pageof 30

Showing results (221-230 of 299) with videos related to

Sort By:
Pageof 30
Virology|July 30, 2005
LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirusThomas Gramberg, Heike Hofmann, Peggy Möller, et al.
The Journal of Infectious Diseases|April 16, 2013
Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu)Ariel Sobarzo, Allison Groseth, Olga Dolnik, et al.
The Journal of Antimicrobial Chemotherapy|April 9, 2014
The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entryGerrit Gehring, Katrin Rohrmann, Nkacheh Atenchong, et al.
Plos Neglected Tropical Diseases|May 2, 2017
External quality assessment study for ebolavirus PCR-diagnostic promotes international preparedness during the 2014 - 2016 Ebola outbreak in West AfricaHeinz Ellerbrok, Sonja Jacobsen, Pranav Patel, et al.
Clinical Chemistry and Laboratory Medicine|August 2, 2012
Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogensThomas Strecker, Jennifer Uhlendorff, Sandra Diederich, et al.
Cell Reports. Medicine|July 20, 2022
Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccineLeonie M Weskamm, Anahita Fathi, Matthijs P Raadsen, et al.
Structure (London, England : 1993)|July 1, 2023
The C-terminus of Sudan ebolavirus VP40 contains a functionally important CX<sub>n</sub>C motif, a target for redox modificationsAnke-Dorothee Werner, Martin Schauflinger, Michael J Norris, et al.
Vaccines|April 23, 2022
Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus NucleoproteinAlexandra Kupke, Asisa Volz, Erik Dietzel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 21, 2015
Field Evaluation of Capillary Blood Samples as a Collection Specimen for the Rapid Diagnosis of Ebola Virus Infection During an Outbreak EmergencyThomas Strecker, Bernadett Palyi, Heinz Ellerbrok, et al.
PNAS Nexus|November 16, 2022
Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic testJohannes Roessler, Dagmar Pich, Manuel Albanese, et al.
Pageof 30